000 | 03645cam a2200481 i 4500 | ||
---|---|---|---|
001 | 20212616 | ||
005 | 20181219192246.0 | ||
008 | 171108t20182018maua b 001 0 eng c | ||
010 | _a 2017049342 | ||
020 | _a9780674975989 | ||
037 |
_cPurchased _nPrism Books,Kadavanthra |
||
041 | _aEnglish | ||
042 | _apcc | ||
082 | 0 | 0 |
_a616.9041 _bHAL/SU |
100 | 1 | _aHall, William | |
245 | 1 | 0 |
_aSUPERBUGS : _ban arms race against bacteria / _cWilliam Hall, Anthony McDonnell, and Jim O'Neill. |
250 | _a1 | ||
260 |
_aLondon _bHarvard University Press _c2018/01/01 |
||
300 | _g246 | ||
500 | _aAntibiotics are powerful drugs that can prevent and treat infections, but they are becoming less effective as a result of drug resistance. Resistance develops because the bacteria that antibiotics target can evolve ways to defend themselves against these drugs. When antibiotics fail, there is very little else to prevent an infection from spreading. Unnecessary use of antibiotics in both humans and animals accelerates the evolution of drug-resistant bacteria, with potentially catastrophic personal and global consequences. Our best defenses against infectious disease could cease to work, surgical procedures would become deadly, and we might return to a world where even small cuts are life-threatening. The problem of drug resistance already kills over one million people across the world every year and has huge economic costs. Without action, this problem will become significantly worse. Following from their work on the Review on Antimicrobial Resistance, William Hall, Anthony McDonnell, and Jim O’Neill outline the major systematic failures that have led to this growing crisis. They also provide a set of solutions to tackle these global issues that governments, industry, and public health specialists can adopt. In addition to personal behavioral modifications, such as better handwashing regimens, Superbugs argues for mounting an offense against this threat through agricultural policy changes, an industrial research stimulus, and other broad-scale economic and social incentives. | ||
505 | _aContents: Part I. The rise of resistance: When a scratch could kill -- The rise of resistance -- Failures in tackling drug-resistant infections -- Part II. Solutions to counter antimicrobial resistance: Incentivizing the creation of new drugs -- Prevention is better than cure -- Reducing unnecessary use of antibiotics in humans -- Agriculture and the environment -- Next steps. | ||
650 | 0 | _aDrug resistance in microorganisms. | |
650 | 0 | _aBacterial diseases | |
650 | 0 | _aMedical policy. | |
650 | 0 | _aHEALTH & FITNESS Diseases General. | |
650 | 0 | _aMEDICAL Clinical Medicine. | |
650 | 0 | _aMEDICAL Diseases. | |
650 | 0 | _aMEDICAL Evidence-Based Medicine. | |
650 | 0 | _aMEDICAL Internal Medicine. | |
650 | 0 | _aPOLITICAL SCIENCE Public Policy Economic Policy. | |
650 | 0 | _aDrug Resistance, Microbial. | |
700 | 1 | _aMcDonnell, Anthony | |
700 | 1 | _aO'Neill, Jim | |
942 | _cLEN | ||
504 | _aIncludes bibliographical references and index. | ||
520 | _aAntibiotics are powerful drugs that can prevent and treat infections, but they are becoming less effective as a result of drug resistance. Superbugs describes this growing global threat, the systematic failures that have led to it, and solutions that governments, industries, and public health specialists can adopt.-- | ||
650 | 0 | _xPrevention. | |
906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
942 | _2ddc | ||
942 | _2ddc | ||
942 | _2ddc | ||
999 |
_c173467 _d173467 |